Mesoblast logo

MSB - Mesoblast Share Price

A$2.24 -0.2  -8.2%

Last Trade - 5:10am

Sector
Healthcare
Size
Mid Cap
Market Cap £609.0m
Enterprise Value £619.1m
Revenue £17.4m
Position in Universe 228th / 1838
Bullish
Bearish
Unlock MSB Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

MSB Revenue Unlock MSB Revenue

Net Income

MSB Net Income Unlock MSB Revenue

Normalised EPS

MSB Normalised EPS Unlock MSB Revenue

PE Ratio Range

MSB PE Ratio Range Unlock MSB Revenue

Dividend Yield Range

MSB Dividend Yield Range Unlock MSB Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
MSB EPS Forecasts Unlock MSB Revenue
Profile Summary

Mesoblast Limited is engaged in developing cell-based medicines. The Company has leveraged its technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic, off-the-shelf cell product candidates target advanced stages of diseases with high, unmet medical needs, including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.

Directors
Last Annual June 30th, 2019
Last Interim December 31st, 2019
Incorporated June 8, 2004
Public Since December 16, 2004
No. of Shareholders: 13,199
No. of Employees: 83
Sector Healthcare
Industry Biotechnology & Medical Research
Index S&P/ASX All Ordinaries , S&P/ASX 300 , ASX Small Ordinaries ,
Exchange Australian Stock Exchange - SEATS
Shares in Issue 533,279,434
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MSB Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MSB
Upcoming Events for MSB
Thursday 28th May, 2020 Estimate
Q3 2020 Mesoblast Ltd Earnings Release
Thursday 27th August, 2020 Estimate
Full Year 2020 Mesoblast Ltd Earnings Release
Similar to MSB
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.